Aesthetic Treatment FAQs — Safety, Costs & Care in Delhi

Aesthetic skin treatments include non-surgical and minimally invasive procedures intended to improve selected aspects of skin appearance, texture and facial contours.

Depending on the concern, options may include chemical peels, microneedling, laser procedures, botulinum toxin injections, dermal fillers and injectable skin-quality treatments.

These procedures work through different mechanisms. Treatments intended to soften expression lines, for example, differ from those used to restore facial volume, manage pigmentation or improve skin texture.

The appropriate approach depends on the underlying concern, individual suitability and realistic expectations rather than the popularity of a particular procedure.

Dermal fillers are injectable materials used to restore or add volume, support selected facial contours and improve certain facial lines.

Hyaluronic acid is commonly used in facial fillers. Depending on the product and clinical indication, treatment may be considered for areas such as the cheeks, lips, chin and jawline.

Treatment planning involves assessing facial anatomy, tissue characteristics, existing volume and the intended correction.

Temporary swelling and bruising may occur. Less common but serious complications include vascular occlusion, tissue injury and visual complications.

For further information about treatment areas and suitability, explore dermal fillers in Delhi.

BOTOX® is a brand of botulinum toxin type A that temporarily reduces activity in selected muscles.

In facial aesthetics, botulinum toxin is commonly used to soften dynamic expression lines, including forehead lines, frown lines and crow's feet.

Dermal fillers work differently. They generally provide volume or structural support rather than reducing muscle activity.

For example, an expression line caused primarily by repeated muscle movement may require a different approach from facial hollowing associated with volume loss.

The treatments are not interchangeable, and neither is appropriate for every concern.

For a more detailed explanation of their mechanisms, uses and clinical differences, read our Botox versus dermal fillers comparison.

Chemical peels use selected solutions to exfoliate the skin at different depths.

Depending on the formulation and individual skin condition, they may be considered for superficial pigmentation, uneven skin tone, selected acne-related concerns and changes in skin texture.

However, not every peel is appropriate for every skin type.

Patients with active inflammation, sensitive skin or a tendency towards post-inflammatory hyperpigmentation may require particular caution.

The peel formulation, treatment depth and frequency should be selected according to the clinical concern and potential risks.

Microneedling uses fine needles to create controlled micro-injuries in the skin.

The resulting healing response may stimulate collagen remodelling and help improve selected concerns, including certain acne scars and uneven skin texture.

Results depend on the nature of the concern, treatment technique, depth and individual response. Some indications may require a series of sessions.

Microneedling should be avoided or postponed where relevant contraindications exist, including active infection in the treatment area.

Learn more about microneedling treatment in Delhi.

Skin boosters are a broad category of injectable treatments intended primarily to improve selected aspects of skin quality, depending on their formulation.

Some contain hyaluronic acid, while others contain different materials.

Conventional volumising fillers are generally intended to provide structural support, restore volume or enhance selected facial contours.

Although both categories may include hyaluronic acid, their formulation, placement and intended effects may differ.

The distinction should be based on the individual product and its intended use rather than assuming that all products marketed as skin boosters behave identically.

Some aesthetic treatments may be appropriate for sensitive skin, but suitability requires individual assessment.

Conditions such as rosacea, eczema, active inflammation, impaired skin-barrier function and previous treatment reactions can influence the choice of procedure.

Certain treatments may require adjustments, while others may need to be postponed or avoided.

Assessment should consider the patient's skin condition, medical history and potential risks associated with the proposed procedure.

No aesthetic treatment should be regarded as universally safe for sensitive skin.

Elective cosmetic botulinum toxin and dermal filler treatments are generally deferred during pregnancy because adequate safety data in pregnant patients are limited.

Breastfeeding requires separate consideration. Available evidence and product recommendations differ, and the absence of demonstrated harm should not be interpreted as proof of safety.

Patients should disclose pregnancy, planned pregnancy or breastfeeding before considering injectable treatment.

Where treatment is purely cosmetic, postponement may be appropriate until the relevant medical considerations have been addressed.

Age requirements depend on the procedure, product, authorised indication and applicable regulations.

Some injectable aesthetic products have specific minimum ages in their product labelling.

For adults, chronological age alone does not establish whether treatment is necessary or appropriate.

Skin characteristics, facial anatomy, medical history, the underlying concern and the patient's expectations are more useful considerations.

Preventive injectable treatment should not be presented as automatically necessary upon reaching a particular age.

Possible side effects depend on the treatment.

Temporary redness, swelling, tenderness and bruising may occur after certain injectable and skin procedures.

Other complications can include infection, allergic reactions, pigmentary changes, unwanted aesthetic outcomes and product-specific adverse effects.

Certain injectable procedures carry rare but serious risks. Dermal filler complications, for example, can include unintended injection into a blood vessel, potentially causing tissue injury or visual loss.

Patients should receive treatment-specific information about risks, contraindications and warning signs before providing informed consent.

For independent medical information, see the US FDA's guidance on dermal filler risks.

Some swelling, tenderness or bruising may be expected after particular injectable procedures.

However, severe or increasing pain, unusual skin blanching, dusky discoloration or rapidly worsening changes following filler treatment may indicate a complication requiring urgent assessment.

Sudden visual changes, loss of vision or symptoms suggestive of a stroke require immediate emergency medical attention.

Patients should receive clear instructions about treatment-specific warning signs and the appropriate contact or emergency pathway before undergoing a procedure.

Serious filler complications can occur even when appropriate precautions have been taken.

Suitability is determined through clinical assessment rather than appearance alone.

Depending on the treatment, the assessment may include:

• The underlying facial or skin concern.
• Relevant medical conditions, medications and allergies.
• Previous aesthetic treatments and adverse reactions.
• Facial anatomy, skin characteristics and treatment goals.
• Potential benefits, contraindications and complications.
• Alternative approaches, including choosing not to undergo treatment.

The purpose is to establish whether the expected benefit of the proposed procedure is appropriate in relation to its risks and limitations.

These treatments address different concerns and may sometimes be incorporated into a coordinated treatment plan.

Botulinum toxin may be considered for selected expression lines, fillers for volume or contour changes, and skin boosters for aspects of skin quality.

However, combining procedures is not automatically preferable to using one appropriately selected treatment.

The proposed sequence, timing and suitability should be assessed individually.

A combination should have a clear treatment rationale rather than follow a standard anti-ageing package.

Some hyaluronic acid fillers can be broken down using hyaluronidase when clinically indicated.

However, dissolving a filler is itself a medical intervention with potential risks, and complete or immediate removal cannot be guaranteed.

Other filler materials, including calcium hydroxylapatite and poly-L-lactic acid, cannot be dissolved using the same method.

Importantly, the possibility of dissolving hyaluronic acid filler does not mean that serious complications are always reversible.

Patients should understand the material being injected, its expected persistence and the options available if an adverse outcome occurs.

The regulatory status of hyaluronidase use for aesthetic filler dissolution depends on the product and jurisdiction.

Certain acne scars may improve with procedures such as microneedling, selected laser treatments or other scar-directed techniques.

The approach depends on the scar type, depth and whether active acne is present.

Rosacea is a separate inflammatory skin condition. It may require medical treatment, while selected laser or light-based procedures can sometimes help persistent redness and visible blood vessels.

Treatments suitable for acne scars are not automatically appropriate for active rosacea.

Establishing the correct diagnosis and controlling inflammation are important before considering an aesthetic procedure.

Treatment depends on the cause, depth and distribution of pigmentation.

Management may include photoprotection, topical medication, selected chemical peels and other carefully chosen procedures.

Melasma frequently requires long-term management, and recurrence is possible.

Patients with darker or pigmentation-prone skin may have an increased risk of post-inflammatory hyperpigmentation after inappropriate or aggressive procedures.

The first step is to identify the underlying cause and assess whether a proposed intervention could worsen the pigmentation.

Selected non-surgical treatments may provide modest improvements in mild skin laxity or firmness.

Depending on the concern, radiofrequency and ultrasound-based procedures may be considered.

However, sagging does not result from loose skin alone. Facial volume loss, changes in deeper tissue support and tissue descent can contribute to its appearance.

A procedure intended to improve skin firmness may therefore be insufficient for significant tissue descent.

Non-surgical treatments cannot reproduce the anatomical changes achieved through an appropriately indicated surgical facelift.

Explore skin-tightening treatments in Delhi.

Chemical peels and laser procedures may sometimes be incorporated into a staged treatment plan.

However, their combined use requires consideration of treatment depth, skin sensitivity, pigmentation risk and recovery.

Performing multiple procedures too close together can increase the possibility of prolonged irritation, inflammation and pigmentary complications.

The appropriate sequence depends on the specific peel, laser technology and individual skin characteristics.

Combining treatments is not automatically more effective than selecting one appropriate procedure.

Dark circles may result from pigmentation, structural under-eye hollowing, thin skin, visible blood vessels, puffiness or a combination of these factors.

Different causes require different treatment approaches.

For example, pigmentation-directed treatment may not improve shadows caused by a tear trough. Similarly, adding filler may be inappropriate when puffiness or prominent under-eye bags are the main concern.

A clinical assessment should identify the principal cause before treatment is recommended.

Learn more about dark circle treatment options in Delhi.

The level of discomfort varies according to the procedure, treatment area and individual sensitivity.

Some injectable treatments involve brief needle-related discomfort. Other procedures, such as deeper microneedling or certain resurfacing treatments, may be more uncomfortable.

Depending on the intervention, topical anaesthetic, local anaesthetic or other appropriate comfort measures may be considered.

Anaesthesia is not required for every treatment, and its use depends on clinical considerations.

Patients should ask what sensations to expect, whether pain control is appropriate and what discomfort may occur during recovery.

Exercise recommendations depend on the procedure, treatment area and individual recovery.

After certain injectable treatments, temporary restrictions on strenuous exercise may be recommended.

Other procedures, particularly those affecting the skin barrier, may require different or longer recovery arrangements.

There is no universal exercise restriction applicable to every aesthetic treatment.

Patients should follow the specific aftercare instructions provided by their treating clinician.

The onset of results varies.

Hyaluronic acid fillers may produce an immediate visible change, although swelling can temporarily affect the appearance.

Botulinum toxin treatment generally begins taking effect over several days, with its full aesthetic effect developing progressively.

Treatments involving collagen remodelling, such as certain microneedling and energy-based procedures, may require weeks or months before their effects can be adequately assessed.

Some procedures require several sessions.

Individual outcomes vary, and no procedure guarantees a particular aesthetic result.

The duration depends on the product, procedure, anatomical area and individual biological response.

Botulinum toxin effects are temporary and commonly persist for several months.

The longevity of hyaluronic acid fillers varies according to product formulation, placement and individual factors.

Skin-quality treatments and collagen-remodelling procedures have different response and maintenance timelines.

Repeat treatment should follow reassessment rather than an automatic schedule.

Maintenance depends on the original concern and the treatment performed.

Consistent photoprotection, appropriate skincare and management of relevant skin conditions may support overall skin health.

However, skincare does not prevent the biological breakdown of every injectable product or stop natural age-related facial changes.

Follow-up appointments may help determine whether further treatment is appropriate.

Additional procedures should be recommended according to individual need rather than as an automatic maintenance package.

Patients should receive aftercare instructions appropriate to the procedure.

These should explain expected recovery symptoms, warning signs, how to contact the treating team and when emergency medical attention is necessary.

If an unexpected reaction occurs, its severity should be assessed and appropriate medical advice obtained.

Some complications require urgent intervention rather than waiting for a routine follow-up appointment.

Before undergoing treatment, patients should ask about the clinic's arrangements for reviewing adverse reactions, accessing appropriate medical assistance and arranging referral where necessary.

For severe pain, rapidly worsening skin changes, sudden visual disturbance or neurological symptoms following filler treatment, seek immediate emergency medical care rather than waiting for a routine clinic response.